Lower Costs with Appropriate Sleep Apnea Testing and Treatment

More than 80% of the approximately 25 million Americans affected by obstructive sleep apnea (OSA) are undiagnosed. When left untreated, OSA increases the risk for serious health complications, including hypertension, stroke, heart disease, diabetes and other comorbidities, which account for approximately $30 billion in increased health care utilization and medication costs. With NIA’s sleep health solution, providers can connect members to the right test to cost-effectively diagnose and treat obstructive sleep apnea.

We can help you lower OSA costs and reduce waste by ensuring appropriate testing for the right patients and the right time. Contact us to learn more.